These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1517902)

  • 1. 'Pleural' and pulmonary carcinosarcomas.
    Mayall FG; Gibbs AR
    J Pathol; 1992 Jul; 167(3):305-11. PubMed ID: 1517902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity, p53 accumulation and neoangiogenesis in pulmonary carcinosarcomas and pulmonary blastomas.
    Theegarten D; Zorn M; Philippou S
    Gen Diagn Pathol; 1998 Apr; 143(5-6):265-70. PubMed ID: 9653906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of diffuse malignant pleural mesothelioma.
    Corson JM
    Semin Thorac Cardiovasc Surg; 1997 Oct; 9(4):347-55. PubMed ID: 9352951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural mesothelioma in situ and its adenocarcinoma simulator.
    Bono F
    Int J Surg Pathol; 2010 Dec; 18(6):519-20. PubMed ID: 21081535
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathology of mesothelioma.
    Corson JM
    Thorac Surg Clin; 2004 Nov; 14(4):447-60. PubMed ID: 15559051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Focal fibrous mesothelioma of the pleura (a morphological study of 7 cases].
    Perevoshchikov AG; Katenkamp D; Raĭkhlin NT
    Arkh Patol; 1989; 51(8):9-15. PubMed ID: 2479366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
    Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistological comparison of primary lung carcinosarcoma and sarcoma.
    Cupples J; Wright J
    Pathol Res Pract; 1990 Jun; 186(3):326-9. PubMed ID: 1696005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
    Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
    Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural mesothelioma with cutaneous extension to chest wall scars.
    Shieh S; Grassi M; Schwarz JK; Cheney RT
    J Cutan Pathol; 2004 Aug; 31(7):497-501. PubMed ID: 15239680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of malignant mesothelioma.
    Sheibani K; Stroup RM
    Pathology (Phila); 1996; 4(1):191-212. PubMed ID: 8953621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
    Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
    Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle aspiration biopsy of pleural metastases from a carcinosarcoma or true malignant mixed tumor of the parotid gland mimicking a mesothelioma.
    Khadse P; Prabhash K; Pramesh CS; Chaturvedi P; Shet T
    Diagn Cytopathol; 2009 Sep; 37(9):680-5. PubMed ID: 19373913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma.
    Lindholm PM; Soini Y; Myllärniemi M; Knuutila S; Heikinheimo M; Kinnula VL; Salmenkivi K
    J Clin Pathol; 2009 Apr; 62(4):339-44. PubMed ID: 19060016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytodiagnosis of malignant mesothelioma on bronchial washing fluid, with immunocytochemical confirmation.
    Bresaola E; Pelosi G
    Acta Cytol; 1997; 41(5):1640-2. PubMed ID: 9305403
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
    Kobayashi M; Takeuchi T; Ohtsuki Y
    Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.